Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

BRCA gene mutations are linked to a higher chance of developing prostate cancer at a younger age and in a more aggressive ...

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

Scientists have found a new method that could treat patients with advanced prostate cancer. Experts at The Institute of ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said. Experts at the Institute of Cancer Research (ICR) in London said men with ...

Experts at the Institute of Cancer Research said men with with BRCA1 and BRCA2 gene mutations are at such high risk they ...

For example, androgens attach to special receptors on the surface of prostate cancer cells, which enables the cells to send the signals they need to grow. Drugs called androgen receptor blockers stop ...

SBRT may ease toxicity, but the lower doses could come at the expense of cancer control, new data indicate. Experts suggest a ...

The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling ...